Joseph Talamo Receives Stock Award at Intensity Therapeutics Inc (INTS) — SEC Form 4, Jan 05, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
28.7K sh
14,179 → 28,661
Equity Change
+102.1%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Joseph Talamo CIK 0001524547 |
CFO
|
Joseph Talamo at Intensity Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Intensity Therapeutics Inc
| 2026-07-20 | Award | — | View |
| 2026-07-01 | Award | — | View |
| 2025-07-02 | Award | — | View |
| 2025-05-06 | Award | — | View |
| 2024-10-23 | Award | — | View |
Non-Derivative Securities Transactions
Footnotes (2)
- F1
- The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). Show more
- F2
- In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025. Show more
Related filings at Intensity Therapeutics Inc
Other insiders at Intensity Therapeutics Inc
GET /v1/forms/4/0001524547-26-000003
API docs
View Original SEC Filing